![Wai Hong Chung](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortune : - $ au 31/05/2026
Wai Hong Chung has been COO, Director & Chief Strategy Officer at Regencell Bioscience Holdings Ltd. since 2023.
Education includes undergraduate studies at Stanford University and the British Columbia Institute of Technology.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 18/03/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
| Sociétés | Poste | Début |
|---|---|---|
| REGENCELL BIOSCIENCE HOLDINGS LIMITED | Directeur des opérations | 01/08/2021 |
Actives
Inactives
Sociétés cotées
Entreprise privées
| Entreprise privées | 3 |
|---|---|
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
British Columbia Institute of Technology
 British Columbia Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Regencell Bioscience Holdings Ltd.
 Regencell Bioscience Holdings Ltd. Pharmaceuticals: MajorHealth Technology Engages in research, development and commercialization of traditional medicine | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national
Choisissez Zonebourse 
